|Last Price$78.19||Day Change (%)0.20%|
|Open Price$77.56||Day Change ($)0.16|
|Day Range77.05–78.47||52-Week Range55.85–79.45|
As of Wed 3/4/2015 5:41:00 PM | USD
Medtronic beats profit and sales expectations
NuVasive: Court Overturns $102 Million Award to Medtronic --Update
NuVasive: Court Overturns $102 Million Award to Medtronic
Ladies and gentlemen, thank you for standing by, and welcome to the Medtronic Fourth Quarter Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session. Thank you.
Actavis set for $20 billion corporate-bond sale
Top managers continue to find opportunities for new-money purchases (albeit fewer than in past periods), while taking full advantage of a rising stock market to book some gains.
Research and Markets: Global Transcatheter Aortic Valve Replacement (TAVR) Market Report: 2015 Edition
The device maker's planned acquisition of Covidien will make it a force to be reckoned with.
The firm is on track to meet our full-year estimates, and our $60 per share fair value estimate and wide moat rating are intact.
Actavis Readies Big Bond Deal